Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up

Fig. 3

Kaplan–Meier estimates of locoregional-free survival (A), distant metastasis-free survival (B), overall survival (C), and disease-free survival (D) for the high-risk group (T1-3N2) treated with IMRT alone and CCRT. P-values were calculated by log-rank test. IMRT, intensity-modulated radiotherapy; CCRT, concurrent chemoradiotherapy; LRFS, locoregional-free survival; DMFS, distant metastasis-free survival; OS, overall survival; and DFS, disease-free survival

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us